Now showing items 1-1 of 1

    • TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer. 

      Fagerholm, R; Khan, S; Schmidt, MK; García-Closas, M; Heikkilä, P; Saarela, J; Beesley, J et al. (Impact Journals, 2017-02-05)
      TP53 overexpression is indicative of somatic TP53 mutations and associates with aggressive tumors and poor prognosis in breast cancer. We utilized a two-stage SNP association study to detect variants associated with breast ...